Chemoinformaics analysis of 1,6,10-DODECATRIEN-3-OL
Molecular Weight | 180.291 | nRot | 7 |
Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
Exact Molecular Weight | 180.151 | nRing | 0 |
Solubility: LogS | -2.436 | nHRing | 0 |
Solubility: LogP | 3.432 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 34.1779 |
nHD | 1 | BPOL | 20.0641 |
QED | 0.471 |
Synth | 3.649 |
Natural Product Likeliness | 2.579 |
NR-PPAR-gamma | 0.165 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.091 |
HIA | 0.009 |
CACO-2 | -4.328 |
MDCK | 0.0000361 |
BBB | 0.945 |
PPB | 0.829862 |
VDSS | 1.254 |
FU | 0.166175 |
CYP1A2-inh | 0.385 |
CYP1A2-sub | 0.401 |
CYP2c19-inh | 0.105 |
CYP2c19-sub | 0.525 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.932 |
CYP2d6-inh | 0.033 |
CYP2d6-sub | 0.668 |
CYP3a4-inh | 0.207 |
CYP3a4-sub | 0.198 |
CL | 9.48 |
T12 | 0.563 |
hERG | 0.002 |
Ames | 0.019 |
ROA | 0.035 |
SkinSen | 0.821 |
Carcinogencity | 0.068 |
EI | 0.979 |
Respiratory | 0.072 |
NR-Aromatase | 0.015 |
Antiviral | No |
Prediction | 0.669124 |